Tellgen Corp (300642) - Total Liabilities
Based on the latest financial reports, Tellgen Corp (300642) has total liabilities worth CN¥539.79 Million CNY (≈ $78.99 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Tellgen Corp to evaluate the company's liquid asset resilience ratio.
Tellgen Corp - Total Liabilities Trend (2012–2025)
This chart illustrates how Tellgen Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300642 total asset value.
Tellgen Corp Competitors by Total Liabilities
The table below lists competitors of Tellgen Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LF Corp
KO:093050
|
Korea | ₩1.30 Trillion |
|
Grupo Traxión S.A.B. de C.V
MX:TRAXIONA
|
Mexico | MX$21.16 Billion |
|
Protec Co. Ltd
KQ:053610
|
Korea | ₩101.04 Billion |
|
Delcath Systems Inc
NASDAQ:DCTH
|
USA | $12.13 Million |
|
Somalogic Inc
NASDAQ:SLGC
|
USA | $68.31 Million |
|
Yuanbao Inc. American Depositary Shares
NASDAQ:YB
|
USA | $1.71 Billion |
|
Changsha Tongcheng Holdings Co Ltd
SHE:000419
|
China | CN¥1.70 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Tellgen Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Tellgen Corp to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tellgen Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tellgen Corp (2012–2025)
The table below shows the annual total liabilities of Tellgen Corp from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥576.38 Million ≈ $84.34 Million |
+149.57% |
| 2024-12-31 | CN¥230.94 Million ≈ $33.79 Million |
+60.33% |
| 2023-12-31 | CN¥144.05 Million ≈ $21.08 Million |
-21.74% |
| 2022-12-31 | CN¥184.07 Million ≈ $26.94 Million |
+79.43% |
| 2021-12-31 | CN¥102.59 Million ≈ $15.01 Million |
-2.48% |
| 2020-12-31 | CN¥105.19 Million ≈ $15.39 Million |
+35.13% |
| 2019-12-31 | CN¥77.84 Million ≈ $11.39 Million |
-1.07% |
| 2018-12-31 | CN¥78.68 Million ≈ $11.51 Million |
+100.17% |
| 2017-12-31 | CN¥39.31 Million ≈ $5.75 Million |
-24.23% |
| 2016-12-31 | CN¥51.88 Million ≈ $7.59 Million |
+34.84% |
| 2015-12-31 | CN¥38.47 Million ≈ $5.63 Million |
+25.22% |
| 2014-12-31 | CN¥30.72 Million ≈ $4.50 Million |
-6.56% |
| 2013-12-31 | CN¥32.88 Million ≈ $4.81 Million |
+270.61% |
| 2012-12-31 | CN¥8.87 Million ≈ $1.30 Million |
-- |
About Tellgen Corp
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more